MBD1 Recombinant Rabbit Monoclonal Antibody [PSH01-79]
cat.: HA721731
Product Type: Recombinant Rabbit monoclonal IgG, primary antibodies
Species reactivity: Mouse, Rat
Applications: WB, IF-Cell, FC
Clonality: Monoclonal
Clone number: PSH01-79
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Storage buffer: PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 70 kDa
Isotype: IgG
Immunogen: Recombinant protein within mouse MBD1 aa 1-200 / 636.
Positive control: NIH/3T3 cell lysate, RAW264.7 cell lysate, C2C12 cell lysate, mouse kidney tissue lysate, mouse brain tissue lysate, mouse lung tissue lysate, mouse spleen tissue lysate, rat brain tissue lysate, NIH/3T3.
Subcellular location: Nucleus, Nucleus matrix, Nucleus speckle, Chromosome
Recommended Dilutions:
  WB
  IF-Cell
  FC

1:1,000
1:100
1:1,000
Uniprot #: SwissProt: Q9Z2E2 Mouse | Q66HB8 Rat
Alternative names: CXXC 3 CXXC-type zinc finger protein 3 CXXC3 MBD 1 Mbd1 MBD1_HUMAN MECP1 COMPLEX Methyl CpG binding domain protein 1 Methyl CpG binding domain protein 1 isoform PCM1 Methyl CpG binding protein MBD1 Methyl CpG binding protein splice variant 1 Methyl CpG binding protein splice variant 2 Methyl CpG binding protein splice variant 3 Methyl CpG binding protein splice variant 4 Methyl-CpG-binding domain protein 1 Methyl-CpG-binding protein MBD1 PCM 1 PCM1 Protein containing methyl-CpG-binding domain 1 Regulator of fibroblast growth factor 2 (FGF 2) transcription RFT The regulator of fibroblast growth factor 2(FGF 2) transcription
Images
HA721731_1.jpg Fig1: Western blot analysis of MBD1 on different lysates with Rabbit anti-MBD1 antibody (HA721731) at 1/1,000 dilution.

Lane 1: NIH/3T3 cell lysate
Lane 2: RAW264.7 cell lysate
Lane 3: C2C12 cell lysate
Lane 4: Mouse kidney tissue lysate
Lane 5: Mouse brain tissue lysate
Lane 6: Mouse lung tissue lysate
Lane 7: Mouse spleen tissue lysate
Lane 8: Rat brain tissue lysate

Lysates/proteins at 30 µg/Lane.

Predicted band size: 70 kDa
Observed band size: 70 kDa

Exposure time: 5 minutes;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA721731) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
HA721731_2.jpg Fig2: Immunocytochemistry analysis of NIH/3T3 cells labeling MBD1 with Rabbit anti-MBD1 antibody (HA721731) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-MBD1 antibody (HA721731) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.

Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
HA721731_3.jpg Fig3: Flow cytometric analysis of NIH/3T3 cells labeling MBD1.

Cells were fixed and permeabilized. Then stained with the primary antibody (HA721731, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.